NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Clinical trial NCT01098266 · COMPLETED

Trial details

NCT number: NCT01098266
Sponsor: AGC Biologics S.p.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Pleural Mesothelioma

Start date: 2010-04-12
Primary completion: 2014-04-29
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.